Erez Aminov - 29 Aug 2025 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role: Chief Executive Officer, Director
Signature: /s/ Erez Aminov
Issuer symbol: MIRA
Transactions as of: 29 Aug 2025
Net transactions value: +$85,625
Form type: 4
Filing time: 03 Sep 2025, 16:05:25 UTC
Previous filing: 30 May 2025
Next filing: 18 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Aminov Erez	Chief Executive Officer, Director	C/O MIRA PHARMACEUTICALS, INC., 1200 BRICKELL AVE. SUITE 1950 #1183, MIAMI	/s/ Erez Aminov	03 Sep 2025	0001986112

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MIRA	Common Stock	Award	$85,625	+62,500	+8%	$1.37	844,700	29 Aug 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan.